A detailed history of Fmr LLC transactions in Insmed Inc stock. As of the latest transaction made, Fmr LLC holds 7,305,130 shares of INSM stock, worth $524 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,305,130
Previous 9,318,894 21.61%
Holding current value
$524 Million
Previous $253 Million 93.59%
% of portfolio
0.03%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$22.0 - $69.71 $44.3 Million - $140 Million
-2,013,764 Reduced 21.61%
7,305,130 $489 Million
Q1 2024

May 13, 2024

BUY
$25.72 - $29.94 $109 Million - $127 Million
4,227,280 Added 83.02%
9,318,894 $253 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $18.4 Million - $25 Million
786,660 Added 18.27%
5,091,614 $158 Million
Q3 2023

Nov 13, 2023

BUY
$19.86 - $26.93 $4.4 Million - $5.97 Million
221,659 Added 5.43%
4,304,954 $109 Million
Q2 2023

Aug 11, 2023

BUY
$16.44 - $21.1 $8.16 Million - $10.5 Million
496,295 Added 13.84%
4,083,295 $86.2 Million
Q1 2023

May 11, 2023

SELL
$16.26 - $21.73 $2.95 Million - $3.94 Million
-181,407 Reduced 4.81%
3,587,000 $61.2 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $3.75 Million - $5.12 Million
221,101 Added 6.23%
3,768,407 $75.3 Million
Q3 2022

Nov 10, 2022

BUY
$20.88 - $28.21 $2.48 Million - $3.35 Million
118,820 Added 3.47%
3,547,306 $76.4 Million
Q2 2022

Aug 12, 2022

BUY
$17.07 - $25.71 $1.08 Million - $1.63 Million
63,548 Added 1.89%
3,428,486 $67.6 Million
Q1 2022

May 13, 2022

SELL
$20.42 - $28.13 $3.68 Million - $5.07 Million
-180,293 Reduced 5.09%
3,364,938 $79.1 Million
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $11.8 Million - $15.3 Million
-456,863 Reduced 11.42%
3,545,231 $96.6 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $7.49 Million - $9.82 Million
-333,312 Reduced 7.69%
4,002,094 $110 Million
Q2 2021

Aug 13, 2021

BUY
$24.17 - $36.01 $105 Million - $156 Million
4,335,406 New
4,335,406 $123 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.71B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.